[Advances in Cardiology] Antiplatelet Therapy in ACS and A-Fib Volume 47 || Dipyridamole in Antithrombotic Treatment

[Advances in Cardiology] Antiplatelet Th

[Advances in Cardiology] Antiplatelet Therapy in ACS and A-Fib Volume 47 || Prasugrel

✍ Serebruany, V.L.; Atar, D. 📂 Article 📅 2012 🏛 S. KARGER AG 🌐 English ⚖ 450 KB

Platelets play a critical role in the pathophysiology of acute coronary syndromes (ACS) and thromboembolic complications associated with atrial fibrillation. Anticoagulant and antiplatelet therapies are central to the treatment of ACS and atrial fibrillation. Over the last several decades, a better

[Advances in Cardiology] Antiplatelet Th

[Advances in Cardiology] Antiplatelet Therapy in ACS and A-Fib Volume 47 || Stents and Antiplatelet Therapy

✍ Serebruany, V.L.; Atar, D. 📂 Article 📅 2012 🏛 S. KARGER AG 🌐 English ⚖ 135 KB

Platelets play a critical role in the pathophysiology of acute coronary syndromes (ACS) and thromboembolic complications associated with atrial fibrillation. Anticoagulant and antiplatelet therapies are central to the treatment of ACS and atrial fibrillation. Over the last several decades, a better

[Advances in Cardiology] Antiplatelet Th

[Advances in Cardiology] Antiplatelet Therapy in ACS and A-Fib Volume 47 || Genetic Considerations

✍ Serebruany, V.L.; Atar, D. 📂 Article 📅 2012 🏛 S. KARGER AG 🌐 English ⚖ 222 KB

Platelets play a critical role in the pathophysiology of acute coronary syndromes (ACS) and thromboembolic complications associated with atrial fibrillation. Anticoagulant and antiplatelet therapies are central to the treatment of ACS and atrial fibrillation. Over the last several decades, a better

[Advances in Cardiology] Antiplatelet Th

[Advances in Cardiology] Antiplatelet Therapy in ACS and A-Fib Volume 47 || Impact of Antiplatelet Therapy in Heart Disease

✍ Serebruany, V.L.; Atar, D. 📂 Article 📅 2012 🏛 S. KARGER AG 🌐 English ⚖ 361 KB

Platelets play a critical role in the pathophysiology of acute coronary syndromes (ACS) and thromboembolic complications associated with atrial fibrillation. Anticoagulant and antiplatelet therapies are central to the treatment of ACS and atrial fibrillation. Over the last several decades, a better

[Advances in Cardiology] Antiplatelet Th

[Advances in Cardiology] Antiplatelet Therapy in ACS and A-Fib Volume 47 || Antiplatelet Therapy in Acute Coronary Syndromes: Ticagrelor

✍ Serebruany, V.L.; Atar, D. 📂 Article 📅 2012 🏛 S. KARGER AG 🌐 English ⚖ 370 KB

Platelets play a critical role in the pathophysiology of acute coronary syndromes (ACS) and thromboembolic complications associated with atrial fibrillation. Anticoagulant and antiplatelet therapies are central to the treatment of ACS and atrial fibrillation. Over the last several decades, a better

[Advances in Cardiology] Antiplatelet Th

[Advances in Cardiology] Antiplatelet Therapy in ACS and A-Fib Volume 47 || Challenges in Atrial Fibrillation

✍ Serebruany, V.L.; Atar, D. 📂 Article 📅 2012 🏛 S. KARGER AG 🌐 English ⚖ 112 KB

Platelets play a critical role in the pathophysiology of acute coronary syndromes (ACS) and thromboembolic complications associated with atrial fibrillation. Anticoagulant and antiplatelet therapies are central to the treatment of ACS and atrial fibrillation. Over the last several decades, a better